CLINICAL PROFILE OF HEART FAILURE

Dr. Yogesh Vinodbhai Solanki, Dr. Alpesh R. Vora

Abstract


BACKGROUND AND OBJECTIVES: The heart failure is major burden to the society and leads to a heavy toll in morbidity, mortality and health
care costs. With increasing incidence of cardiovascular disease, India is witnessing a simultaneous surge in incidence of heart failure, including
among relatively younger men and women who were earlier considered out of the risk bracket of this condition. This study is an attempt to evaluate
clinical profile of heart failure in patients admitted to Sir Takhtasinhji General Hospital, Bhavnagar.
METHOD: This study was done on 100 patients admitted in Sir T. General Hospital, Bhavnagar with clinical evidence of heart failure.
RESULTS: Male gender (55%) had higher incidence of heart failure as compared to female (45%) with mean age of 47.43± 14.69 years.
Breathlessness was most common presenting symptom and bilateral basal crepitation was most common sign. IHD was most common cause of
heart failure followed by VHD. Lack of compliance was most common precipitating factor whereas HTN was most common co morbidity.
CONCLUSION: Incidence of heart failure is more common in the middle age group patients i.e., in age group of 40 to 50 years 29%. IHD is most
common cause of heart failure. HFrEF was found in (57%) of patients and HFpEF was found in (43%) of patients. The mortality in the present study
was (7%) and survival was (93%).


Keywords


IHD-Ischemic heart disease, VHD -Valvular heart disease, HTN -Hypertension, HFrEF- Heart failure with reduced ejection fraction, HFpEFHeart failure with preserved ejection fraction.

Full Text:

PDF

References


Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Drazner MH; 2013 ACC/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2013; 128: e240-e327.

Rosamond W1, Flegal K, Friday G, Furie K, Go A, Greenlund K et al.; Heart disease and stroke statistics--2007 update: Circulation, 2007; 115(5): e69-e171.

Reddy S, Bahl A, Talwar KK; Congestive heart failure in Indians: How do we improvediagnosis & management?: Indian J Med Res., 2010; 132(5): 549–560.

Huffman MD, Prabhakaran D; Heart failure: epidemiology and prevention in India, Natl Med J India. 2010; 23(5): 283-288.

Swedberg K, Cleiand J, Dangle H, Dexler H, Follath F, Komagda M et al.; Guidelines for diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European Heart Journal, 2005; 26: 1115-1140

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891–975.

Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;128:1810–52.

van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure:the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016;18:242–52.

Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30–41.

Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251–59.

Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update:a report from the American Heart Association. Circulation 2016;133:e38–360.

Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States:a policy statement from the American Heart Association. Circ Heart Fail 2013;6:606–19.

Crespo-Leiro MG, Anker SD, Maggioni AP, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT):1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016;18:613–25.

Braunwald E. Heart failure. JACC Heart Fail 2013;1:1–20.

Damman K, Valente MA, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure:an updated meta-analysis. Eur Heart J 2014;35:455–69.

Valentova M, von Haehling S, Bauditz J, et al. Intestinal congestion and right ventricular dysfunction:a link with appetite loss, inflammation, and cachexia in chronic heart failure. Eur Heart J 2016;37:1684–91.

McMurray JJ, Packer M, Desai AS, et al, for the PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993–1004.

Shah AM, Claggett B, Sweitzer NK, et al. Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 2015;132:402–14.

Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction:comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263–71.

Franssen C, Chen S, Unger A, et al. Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 2016;4:312–24.

Kelkar AA, Spertus J, Pang P, et al. Utility of patient-reported outcome instruments in heart failure. JACC Heart Fail 2016;4:165–75.

McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803–69.

Pocock SJ, Ariti CA, McMurray JJ, et al. Predicting survival in heart failure:a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013;34:1404–13.

Cikes M, Solomon SD. Beyond ejection fraction:an integrative approach for assessment of cardiac structure and function in heart failure. Eur Heart J 2016;37:1642–50.

Erdei T, Smiseth OA, Marino P, Fraser AG. A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group. Eur J Heart Fail 2014;16:1345–61.

Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death:a systematic review and meta-analysis. Lancet 2016;387:957–67.

Wright JT Jr, Williamson JD, Whelton PK, et al, for the SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103–16.


Refbacks

  • There are currently no refbacks.